Journal of Signal Transduction

Journal of Signal Transduction / 2012 / Article

Review Article | Open Access

Volume 2012 |Article ID 931215 |

Yusuke Kanamaru, Shiori Sekine, Hidenori Ichijo, Kohsuke Takeda, "The Phosphorylation-Dependent Regulation of Mitochondrial Proteins in Stress Responses", Journal of Signal Transduction, vol. 2012, Article ID 931215, 12 pages, 2012.

The Phosphorylation-Dependent Regulation of Mitochondrial Proteins in Stress Responses

Academic Editor: Rudi Beyaert
Received22 Apr 2012
Accepted10 Jun 2012
Published15 Jul 2012


To maintain cellular homeostasis, cells are equipped with precise systems that trigger the appropriate stress responses. Mitochondria not only provide cellular energy but also integrate stress response signaling pathways, including those regulating cell death. Several lines of evidence suggest that the mitochondrial proteins that function in this process, such as Bcl-2 family proteins in apoptosis and phosphoglycerate mutase family member 5 (PGAM5) in necroptosis, are regulated by several kinases. It has also been suggested that the phosphorylation-dependent regulation of mitochondrial fission machinery, dynamin-related protein 1 (Drp1), facilitates appropriate cellular stress responses. However, mitochondria themselves are also damaged by various stresses. To avoid the deleterious effects exerted by damaged mitochondria, cells remove these mitochondria in a selective autophagic degradation process called mitophagy. Interestingly, several kinases, such as PTEN-induced putative kinase 1 (PINK1) in mammals and stress-responsive mitogen-activated protein (MAP) kinases in yeast, have recently been shown to be involved in mitophagy. In this paper, we focus on the phosphorylation-dependent regulation of mitochondrial proteins and discuss the roles of this regulation in the mitochondrial and cellular stress responses.

1. Introduction

Mitochondria play a fundamental role in cells, serving as the “powerhouses” that produce ATP through the process of oxidative phosphorylation. In addition to supplying cellular energy, mitochondria are involved in the response to several cellular stresses, such as cell death signaling and antiviral immunity [13]. However, mitochondria themselves are also exposed to various stresses. For example, leakage of the high-energy electrons in the respiratory chain leads to the formation of reactive oxygen species (ROS), which can damage mitochondrial DNA (mtDNA). Mutations in mtDNA result in enzymatic abnormalities in the mitochondrial respiratory chain and further oxidative stress. This vicious cycle has been considered to be involved in a wide range of human diseases, such as metabolic, aging, and neurodegenerative diseases [4]. Thus, the quality of mitochondria must be continuously monitored and maintained by various strategies.

Mitochondria are dynamic organelles that constantly fuse and divide [5]. These dynamic properties are important for the maintenance of mitochondrial functions, which ultimately contribute to cell survival. A certain degree of mitochondrial damage, including mtDNA mutations, can be rescued by mitochondrial fusion, which allows mitochondrial content mixing within a cell (see Section 2). However, severe mitochondrial damage impairs their fusion and result in mitochondrial fragmentation. The resulting fragmented mitochondria are then selectively removed by an autophagic process, termed mitophagy (see Section 3). In other cases, when cells are critically damaged, the mitochondria act as a hub of cell death pathway signaling (see Sections 4 and 5). Several apoptosis-promoting factors are released from mitochondria, and many apoptosis-regulating proteins exert their roles on mitochondria; thus, it has been well documented that mitochondria have crucial roles in apoptosis [2]. In addition, recent studies have revealed that mitochondria also contribute to necroptosis, another type of cell death [6].

Recently, the development of new mass spectrometry-based technologies has led to the discovery of many novel phosphorylation sites on a variety of mitochondrial proteins [7]. Interestingly, it has been suggested that the phosphorylation-dependent regulation of mitochondrial proteins appear to have important roles in mitochondrial and cellular stress responses. In this paper, we will summarize recent research related to mitochondria, especially focusing on the phosphorylation-dependent regulation of various mitochondrial proteins.

2. Mitochondria Are Dynamic Organelles

Mitochondria are highly dynamic organelles that constantly change shape and form flexible reticular networks [5]. Mitochondrial morphology is controlled by a balance of fusion and fission. These events are known to be regulated by the members of the dynamin superfamily of large GTPases, specifically dynamin-related protein 1 (Drp1), the mitofusins MFN1 and MFN2, and optic atrophy type I (OPA1) (Figures 1(a) and 1(b)). Drp1 is a cytosolic protein that is involved in mitochondrial fission, whereas OPA1 and mitofusins reside in mitochondria and mediate their fusion. The recruitment of Drp1 from the cytosol to mitochondrial fission sites involves Fis1, a mitochondrial integral outer membrane protein that is essential for fission. Why do mitochondria continually fuse and divide? Recent studies have shown that these events are required to maintain functional mitochondrial populations in the cell. For example, fusion is thought to allow the exchange of contents between intact and dysfunctional mitochondria. This “content mixing” allows the replacement of damaged material, such as mtDNA that harbors mutations, contributing to the suppression of further damage and mitochondrial homogeneity [8, 9]. In contrast, fission is thought to allow the segregation of severely damaged mitochondria from healthy mitochondrial networks [10]. These segregated damaged mitochondria are delivered to autophagosomes and ultimately degraded (see Section 3 for details). Consistent with these implications of physiological importance of mitochondrial dynamics, the knockout of any of these genes in mice causes embryonic lethality [1113]. In addition, some mitochondrial genes are known to cause some types of neurodegenerative diseases. Mutations in Mfn2 cause the Charcot-Marie-Tooth type 2A (CMT2A) [14], one of the most common hereditary neuropathies, and mutations in OPA1 are the predominant cause of autosomal dominant optic atrophy (DOA), a heritable form of optic neuropathy [15, 16]. These lines of genetic evidence indicate that the dynamic properties of mitochondria may have important roles, particularly in neurons [5].

2.1. Drp1 Phosphorylation

In contrast to mitochondria-localized OPA1 and mitofusins, the majority of Drp1 protein is cytoplasmic [5]. Thus, the localization of Drp1 to mitochondria has emerged as a key regulatory step for mitochondrial fission. Recent studies have suggested that the phosphorylation of Drp1 at Ser637 is an important regulatory modification. This phosphorylation has been reported to be regulated by the opposing actions of PKA, cAMP-dependent protein kinase [17], and calcineurin, a Ca2+-and calmodulin-dependent protein phosphatase [18]. This modification appears to inhibit mitochondrial fission by inhibiting Drp1 recruitment to mitochondria and/or the reduction of its GTPase activity (Figure 1(c)) [17, 18].

2.2. The Control of Mitochondrial Dynamics during Stress Response through the Phosphorylation of Drp1

Several lines of evidence revealed that regulated changes in mitochondrial morphology through the phosphorylation of Drp1 at Ser637 determine cell fate under various stresses, including starvation and hypoxia [19, 20].

During starvation, mitochondria were reported to elongate through the PKA-mediated phosphorylation of Drp1 on Ser637 [19]. Because the genetic or pharmacologic blockade of mitochondrial elongation promotes starvation-induced cell death, mitochondrial elongation is considered to protect the cell against starvation. Although starvation is one of the most common inducers of a self-degradation system called macroautophagy, elongated mitochondria seem to be spared from autophagy. Retained mitochondria help to maintain the cellular ATP level, leading to sustained cell viability [19]. Mitochondrial hyperfusion has also been reported to protect against apoptosis under other stress conditions, such as UV irradiation and actinomycin D treatment, through a different set of molecular mechanisms [21]. These findings indicate that mitochondrial elongation is an important and effective stress response to ensure cell survival.

In contrast, hypoxia induces mitochondrial fission by suppressing the phosphorylation of Drp1 on Ser637 [20]. The E3 ubiquitin ligase Siah2 and the mitochondrial scaffold protein AKAP121 are the key regulators of hypoxia-induced mitochondrial fission (Figure 1(c)). The A-kinase anchor protein (AKAP) family is composed of scaffold proteins that tether PKA and other signaling molecules to distinct subcellular organelles. AKAP121 is associated with mitochondria [22] and facilitates the PKA-mediated phosphorylation of Drp1 at the mitochondria [20]. Siah2 was originally identified as a hypoxia-responsive E3 ligase that ubiquitinates PHD enzymes [23]. PHD enzymes mediate the prolyl hydroxylation of hypoxia-inducible factor 1α (HIF1α), a central regulator of the cellular response to hypoxia. Because the prolyl hydroxylation of HIF1α is a prerequisite for its recognition by the von Hippel-Lindau protein (pVHL) and subsequent proteasomal degradation, the Siah2-mediated degradation of PHD relieves HIF1α from degradation and thus stabilizes HIF1α [23]. Interestingly, Siah2 also ubiquitinates AKAP121 and promotes its degradation under hypoxic conditions [20]. The reduced availability of AKAP121 suppresses the PKA-mediated phosphorylation of Drp1 and facilitates the Drp1-Fis1 interaction, resulting in mitochondrial fission. In cells lacking Siah2, hypoxia-induced fission is suppressed, and this is correlated with high AKAP121 levels and Drp1 phosphorylation in the mitochondrial fraction, ultimately leading to the suppression of hypoxia-induced cell death.

3. The Phosphorylation-Dependent Regulation of Mitophagy, a Mitochondrial Quality Control System

As mentioned above, mitochondrial fusion is one mitochondrial quality control system. However, when mitochondria are severely damaged, other stress responses are induced [24].

Autophagy is a bulk degradation system of cytoplasmic contents (Figure 2(a)) [25]. Upon induction of autophagy, a double-membrane compartment, termed the isolation membrane, engulfs a portion of cytoplasm, including macromolecules and organelles, and forms autophagosomes. The late autophagosome fuses with the lysosome to form autolysosomes, which degrades the engulfed contents. Autophagy is a highly conserved system among eukaryotes and important for many biological processes, such as cell survival during starvation, development, intracellular clearance, and immune responses. In the 1990s, genetic studies in yeast identified a series of autophagy-related (Atg) genes [26, 27]. The Atg proteins are involved in autophagosome formation and are divided into several functional groups [28]. Among them, Atg1 and its mammalian homologs Unc51-like kinase 1 and 2 (ULK1/2) function as the most upstream regulators of autophagosome formation in yeast and mammal, respectively. Under nutrient-rich conditions, the Atg1/ULK complex is suppressed by mammalian target of rapamycin complex 1 (mTORC1). Upon nutrient starvation, the Atg1/ULK complex is activated and recruited to autophagosome formation sites, such as pre-autophagosomal structure (PAS) in yeast and a specialized domain of the ER in mammals. At these sites, another functional unit, the class III phosphatidylinositol 3-kinase complex, produces phosphatidylinositol 3-phosphate (PI3P), and the PI3P-enriched membrane subdomain provides a platform for recruiting other molecules and thus for biogenesis of autophagosomes. The Atg proteins also function as critical components of the two ubiquitin-like conjugation systems; one is the Atg12 conjugation system that produces the Atg12-Atg5-Atg16 complex and the other is the Atg8/LC3-phosphatidylethanolamine (PE) conjugation system that plays important roles in the elongation and closure of the isolation membrane.

Although autophagy has been considered an essentially nonselective process, some proteins and organelles can be specifically recognized by autophagosomes. The autophagy-mediated selective degradation of organelles is thought to be a mechanism for eliminating damaged organelles to maintain cellular homeostasis. Because mitochondria are a major source of ROS, the harmful but inevitable byproduct of oxidative phosphorylation, it is especially important for the cell to monitor and regulate the quality and quantity of mitochondria. Mitophagy, the autophagy-mediated degradation of mitochondria, is one system that exists for this purpose [24]. Recent studies have identified the detailed molecular mechanisms responsible for the selectiveness of mitophagy. Moreover, it has been suggested that several kinases are involved in the precise regulation of mitophagy. In the following subsections, we focus on several kinases that regulate mitophagy in yeast and mammals.

3.1. Atg32 Is a Critical Regulator of Mitophagy in Yeast

In yeast, two selective autophagy pathways have been well described: the cytoplasm-to-vacuole targeting (Cvt) pathway, which delivers vacuolar proenzymes, such as proaminopeptidase I and α-mannosidase, to the vacuole, and the pexophagy pathway, which induces the selective degradation of peroxisomes [29]. Recently, two groups have reported that mitochondria are also selectively degraded by autophagy under some growth conditions in yeast [30, 31]. They performed a genome-wide visual screen for mutants that are defective in mitophagy and identified Atg32 as a critical regulator of mitophagy in yeast (Figure 2(b)). Atg32 is a single membrane-spanning protein that is anchored on the mitochondrial surface. Atg32 binds to Atg11, which serves as an adaptor for the Cvt pathway and pexophagy by linking cargos to the autophagy machinery and to Atg8, which is essential for autophagosome formation. Atg32 binds to Atg8 through the WXXI/L/V motif in its N-terminus, a conserved motif that serves as a binding site for Atg8 family proteins. In the atg32 Δ strain, mitophagy is completely blocked, but other autophagy pathways, including nonselective macroautophagy and other types of selective autophagy, are not affected, indicating that Atg32 is mitophagy specific.

The expression level of Atg32 is dramatically increased under mitophagy-inducing conditions in an ROS-dependent manner [30], indicating that Atg32-mediated mitophagy in yeast is regulated at least in part by Atg32 induction. In addition, recent studies have suggested that Ser114 and Ser119 on Atg32 are phosphorylated when mitophagy is induced [32]. Specifically, the phosphorylation of Atg32 at Ser114 is required for the Atg32-Atg11 interaction. Because Atg11 is known to recruit specific cargoes to the pre-autophagosomal structure (PAS), where the autophagosome is generated, the phosphorylation of Atg32 is required for the efficient delivery of mitochondria to the PAS. The phosphorylation of Atg32 at these sites is mediated by downstream components of the yeast mitogen-activated protein (MAP) kinase cascade, Hog1 and Pbs2 [32]. Although Hog1 and Pbs2 are activated in response to hyperosmotic stress and are involved in the osmoregulatory signal transduction cascade (the HOG signaling pathway), they are also activated under mitophagy-inducing conditions [33]. These findings suggest that mitophagy in yeast is strictly regulated through Atg32 phosphorylation, which is exerted by the interplay of cytosolic stress-responsive MAP kinases and the mitochondrial Atg32.

Although the physiological role of mitophagy in yeast remains unclear, it has recently been reported that undegraded mitochondria in the atg32 Δ strain produce excess ROS, which cause additional mitochondrial damage and lead to even further accelerated ROS production. This vicious cycle ultimately results in the mitochondrial DNA deletion [34]. These findings suggest that mitophagy prevents excess ROS production by eliminating damaged mitochondria.

3.2. PINK1-Parkin-Dependent Mitophagy in Mammals

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The causes of dopaminergic neuronal cell death in PD remains elusive, but many studies have suggested that mitochondrial dysfunction is likely to be an important factor. Specifically, the identification of the Ser/Thr kinase PINK1 (PTEN-induced putative kinase 1) as a gene responsible for early-onset autosomal recessive PD reinforced the link between mitochondria and PD because PINK1 is localized to the mitochondria [35]. Although it has been reported that PINK1 can phosphorylate some mitochondrial proteins either directly or indirectly, including the chaperone TRAP1 [36] and the protease HtrA2 [37], the function of PINK1 was not fully clear. A major breakthrough was made in a genetic study using Drosophila melanogaster [38]. This study revealed that PINK1 and the cytoplasmic E3 ligase Parkin, another gene responsible for early-onset autosomal recessive PD, function in the same pathway and that PINK1 functions upstream of Parkin. This study led to the discovery that PINK1 and Parkin cooperatively induce mitophagy to eliminate damaged mitochondria [39]. PINK1/Parkin-dependent mitophagy is only observed when cells are treated with the chemical reagent CCCP (carbonyl cyanide m-chlorophenyl hydrazone), which causes mitochondrial depolarization. Because CCCP disrupts the proton gradient across the mitochondrial inner membrane and thus dissipates the mitochondrial membrane potential (ΔΨm) that is required for oxidative phosphorylation, loss of mitochondrial membrane potential (ΔΨm) by CCCP treatment is regarded as a hallmark of damaged mitochondria. It has been reported that PINK1 is rapidly and constitutively degraded in healthy mitochondria but stabilized on the surface of mitochondria in response to ΔΨm (Figure 2(c)) [4042]. Stabilized PINK1 acts as a marker of damaged mitochondria and recruits Parkin to the mitochondria [43]. Although the detailed mechanism by which the PINK1/Parkin complex recruits the autophagosome remains to be investigated, Parkin ubiquitinates substrates on mitochondria, leading to their proteasomal degradation and ultimately the destruction of the entire damaged mitochondria via autophagy [44, 45]. Importantly, many pathogenic mutations of PINK1 and Parkin fail to induce mitophagy, suggesting a model in which the impairment of PINK1/Parkin-mediated elimination of damaged mitochondria by mitophagy may contribute to PD pathogenesis [40, 41].

Interestingly, the kinase activity of PINK1 is required for the recruitment of Parkin to mitochondria and subsequent mitophagy [40, 41]. Although the substrate of PINK1 in the context of mitophagy has not been identified, a recent study has revealed that PINK1 regulates mitochondrial motility by phosphorylating Miro, a component of the motor/adaptor complex that mediates the axonal transport of mitochondria [46]. As mentioned in Section 2, mitochondria form a dynamic network, and the appropriate distribution of the mitochondrial network is important for many cellular functions, especially in highly polarized cells, such as neurons [47]. For example, in neurons, the appropriate positioning of mitochondria at the synapse is thought to be required to maintain local ATP levels for the generation of new synaptic branches [48]. Long-range mitochondrial transport from the soma to distal axonal and dendritic regions depends on the polarity and organization of neuronal microtubules as well as on the action of the molecular motor complex, which includes kinesin-1 heavy chain (KHC) (a motor protein), Milton (a kinesin-associated protein), and Miro (a mitochondrial Rho GTPase) (Figure 3) [48]. In this complex, Miro links directly to mitochondria, whereas Milton links indirectly to microtubule through KHC. PINK1 interacts with Miro in a CCCP-dependent manner and phosphorylates Ser156 on Miro, which promotes its degradation by the proteasome [46]. Interestingly, the CCCP-dependent degradation of Miro is promoted by the overexpression of Parkin, indicating that PINK1 and Parkin cooperatively regulate Miro expression. Whereas the PINK1/Parkin-mediated degradation of Miro completely blocks mitochondrial motility, the Miro S156A mutant is resistant to degradation and inhibits PINK1/Parkin-mediated mitochondrial arrest. Although the physiological relevance of CCCP-dependent mitochondrial arrest is not fully understood, at least two possibilities have been proposed: one, this arrest may prevent the mitochondrial fusion, and two, the arrest may sequester the damaged mitochondria and facilitate their efficient delivery to autophagosomes [46].

4. Mitochondria Are Platforms for Apoptosis Execution

When cells undergo sufficient damage, apoptosis is induced. Apoptosis is a programmed process for eliminating damaged cells, and it is considered an important strategy for maintaining organismal homeostasis.

All pathways to apoptosis converge on the activation of caspases, a family of cysteinyl aspartate proteases. There are two caspase families, the initiator caspases (caspase 8 and 9) and executor caspases (caspase 3, 6, and 7). Apoptosis is divided into two distinct pathways, depending on which initiator caspases are involved [49]. One pathway, known as the extrinsic pathway, is induced by cell surface death domain-containing receptors, such as Fas and tumor necrosis factor (TNF) receptors. In this pathway, caspase 8 is recruited to the cytoplasmic region of each receptor through the adaptor protein Fas-associated death domain (FADD) and subsequently activated. The second pathway, known as the intrinsic pathway, is activated by various cytotoxic insults, such as viral infection, DNA damage, and glucose deprivation. This pathway is also called the Bcl-2-regulated or mitochondrial pathway because the mitochondria play an important role in the activation of caspase 9, the initiator caspase of this pathway, and this step is strictly controlled by the Bcl-2 family of mitochondrial proteins [50].

Bcl-2 family members have been grouped into three classes; Bcl-2-like proteins (e.g., Bcl-2 and Bcl-xL), which inhibit apoptosis, BAX-like proteins (e.g., BAX and BAK), which promote apoptosis, and the so-called BH3-only proteins (e.g., BAD, BID, PUMA, and NOXA), which are also proapoptotic but share only the BH3 domain with other Bcl-2 family members (Figure 4(a)).

The proapoptotic effects of BAX and BAK are executed through their activities on mitochondria [50]. These proteins are thought to form pores in mitochondrial membranes and induce the release of soluble proapoptotic mitochondrial proteins, such as cytochrome c and Smac/DIABLO, into the cytosol. This process is called mitochondrial outer membrane permeabilization (MOMP). Once cytochrome c is released, it binds to APAF1 and leads to the assembly of a heptameric protein ring, the so-called “apoptosome,” that can bind to procaspase 9 and trigger its activation by promoting its self-cleavage [2]. Under normal conditions, antiapoptotic Bcl-2-like proteins, such as Bcl-2 and Bcl-xL, dimerize with proapoptotic BAX-like proteins, such as BAX and BAK, and suppress their proapoptotic activities [50]. However, once cells are exposed to apoptotic stimuli, BH3-only proteins are activated and sequester the antiapoptotic Bcl-2-like proteins from BAX and BAK, freeing BAX and BAK to carry out their proapoptotic functions.

Because proapoptotic BH3-only proteins function as the initial sensors of diverse apoptotic stimuli, their activity must be precisely regulated. Some BH3-only proteins are known to be induced by specific transcription factors [50]. For example, NOXA and PUMA are induced by the tumor suppressor p53 in response to DNA damage. Other BH3-only proteins are activated posttranslationally [50]. For example, the caspase-8-mediated cleavage of BID downstream of death receptor signaling promotes the translocation of BID to the mitochondria, which leads to BAX/BAK activation. In addition, several lines of evidence have suggested that Bcl-2 family proteins are regulated by phosphorylation. In the following subsections, we focus on the phosphorylation-dependent regulation of Bcl-2 family proteins and their connection to the mitochondrial apoptosis pathway.

4.1. Phosphorylation-Dependent Regulations of BAD

The balance between prosurvival and prodeath Bcl-2 family proteins determines whether a cell lives or dies. It has been reported that survival signals inhibit the proapoptotic activity of Bcl-2 family members and tilt the balance toward survival. BAD was originally identified as a Bcl-2 binding protein and was the first cell death component to be identified as a regulatory target of survival signaling [51]. BAD selectively dimerizes with Bcl-xL or Bcl-2 and inhibits their antiapoptotic activity (Figure 4(b)). BAD contains at least three inhibitory phosphorylation sites, Ser112, Ser136, and Ser155 [52, 53]. These sites are phosphorylated in response to several survival-promoting cytokines, including IL-3, PDGF, IGF-1, and BDNF. The phosphorylation of BAD at Ser112 and Ser136 creates a 14-3-3 protein-binding consensus motif, promoting the interaction of BAD with 14-3-3 proteins [52]. The 14-3-3 proteins sequester BAD in the cytosol and inhibit its binding to the antiapoptotic proteins Bcl-xL and Bcl-2, thereby suppressing the proapoptotic activity of BAD. Several kinases that mediate the phosphorylation of these sites have been identified, including RSK [54], PKA [55], Pak1/5 [56, 57], and Pim-1 [58] for Ser112; Akt [59], p70S6K [60], and Pak1 [56] for Ser136. As mentioned in Section 2.2, PKA is targeted to mitochondria by the mitochondria-tethered AKAP protein. PKA also phosphorylates BAD in a mitochondrial AKAP-dependent manner [55]. The identification of another phosphorylation site, Ser155, on BAD led to the elucidation of a more detailed mechanism of BAD inactivation [53]. The recruitment of 14-3-3 proteins to BAD increases the access of survival-promoting kinases to BAD Ser155 (Figure 4(b)). The phosphorylation of Ser155 is considered to permanently inhibit the dimerization of BAD and the antiapoptotic proteins Bcl-xL or Bcl-2. To examine the physiological roles of these inhibitory phosphorylation sites of BAD in vivo, Datta et al. generated knock-in mice harboring three BAD point mutations: S112A, S136A, and S155A [61]. These mice exhibit reduced numbers of pro-lymphocytes of the T-cell and B-cell lineage because their survival-promoting cytokine IL-7 is unable to suppress the proapoptotic activity of BAD. Moreover, primary cultured cells derived from these mutant mice are hypersensitive to apoptosis-inducing stimuli because of increased cytochrome c release from the mitochondria. These findings indicate that the survival factor-dependent phosphorylation of BAD raises the threshold at which mitochondria release cytochrome c in response to apoptotic stimuli [61].

Although these phosphorylations inhibit BAD proapoptotic function, it has been suggested that BAD phosphorylation at Ser128 promotes apoptosis [62, 63]. Ser128 has been reported to be phosphorylated by the stress-responsive MAP kinase c-Jun N-terminal kinase (JNK) [62] and the cell cycle-regulated kinase Cdc2 [63]. When Ser128 is phosphorylated, the interaction of BAD with 14-3-3 proteins is disrupted, promoting the apoptotic effect of BAD [63]. It has also been reported that JNK exerts its proapoptotic function by phosphorylating Ser184 on 14-3-3 and promoting the dissociation of 14-3-3 from BAD [64]. In addition, the proapoptotic activity of BAD has been reported to be enhanced by dephosphorylation. The calcineurin-mediated dephosphorylation of BAD induces the translocation of BAD to the mitochondria, promoting its dimerization with Bcl-xL and subsequent BAD-mediated apoptosis [65].

4.2. The Phosphorylation-Dependent Regulation of Bcl-2

In addition to the proapoptotic protein BAD described above, the antiapoptotic protein Bcl-2 is also regulated by phosphorylation. In particular, the phosphorylation of Bcl-2 induced by microtubule inhibitors has been examined. Haldar et al. first reported that Bcl-2 was phosphorylated in response to taxol, a well-studied microtubule-damaging agent [66]. Later, Thr69, Ser70, and Ser87 were found to be phosphorylated in cells treated with taxol [67]. When these residues were substituted with alanine, the antiapoptotic activity of Bcl-2 was augmented. Several reports support the hypothesis that the phosphorylation of Bcl-2 suppresses its antiapoptotic activity. However, other reports argue that the phosphorylation of Bcl-2 at Ser70 promotes its antiapoptotic activity [68]. Unfortunately, no sufficient explanation for this discrepancy has been provided to date.

Because other microtubule inhibitors, such as vincristine, vinblastine, and nocodazole, also induce Bcl-2 phosphorylation, a relationship between the cell cycle and Bcl-2 phosphorylation was proposed. Furthermore, it has been reported that Bcl-2 Ser70 is phosphorylated by JNK1 in G2/M phase [67]. Although it is not clear why the antiapoptotic activity of Bcl-2 must be suppressed at G2/M, one possibility is that lowering the threshold for apoptosis might ensure the elimination of cells with aberrant chromosomal segregation.

5. PGAM5 Is a Mitochondrial Ser/Thr Protein Phosphatase That Regulates Multiple Cell Death Pathways

In addition to the mitochondrial kinases, there are also mitochondrial phosphatases; we identified phosphoglycerate mutase family member 5 (PGAM5) as a novel Ser/Thr protein phosphatase in the mitochondria [69]. We identified PGAM5 as a binding protein of apoptosis-signal regulating kinase 1 (ASK1), a stress-responsive MAPKKK that activates the JNK and p38 MAPK pathways. PGAM5 belongs to the PGAM family, an evolutionarily conserved family of enzymes that convert 3-phosphoglycerate to 2-phosphoglycerate during glycolysis [70]. Although a common catalytic domain, the PGAM domain, is also conserved in PGAM5, we found that PGAM5 lacks mutase activity and instead acts as a Ser/Thr protein phosphatase. When the conserved histidine residue that is known to function as a phospho-acceptor in the mutase reaction is disrupted by mutagenesis, PGAM5 completely loses its phosphatase activity. Moreover, the phosphatase activity of PGAM5 is required for the activation of stress-responsive MAP kinase pathways. Together with the previous report that PGAM5 is localized in mitochondria through its N-terminal transmembrane domain [71], these findings indicate that PGAM5 is a novel mitochondria-resident Ser/Thr protein phosphatase that might be involved in the mitochondrial and/or cellular stress responses [69].

PGAM5 was also identified as a novel substrate of the Keap1-dependent ubiquitin ligase complex [71, 72]. Keap1 is a BTB-Kelch substrate adapter for the Cul3-dependent E3 ubiquitin ligase complex. The best-studied substrate of Keap1 is Nrf2, a transcription factor that regulates the expression of various cellular redox state-regulating proteins, including antioxidant enzymes. Under normal conditions, Nrf2 is constitutively degraded in a Keap1-dependent manner. However, oxidative stress modifies some cysteine residues on Keap1 and disrupts the formation of a functional E3-ligase complex, leading to the stabilization of Nrf2. The N-terminus of PGAM5 contains a Keap1-binding consensus motif, E(S/T)GE, similar to that found in Nrf2. Although it is not known why PGAM5 is degraded in a Keap1-dependent manner, the notion that mitochondria are a major source of ROS raises the possibility that the Keap1-PGAM5 complex might be involved in mitochondrial redox homeostasis.

The PGAM5 protein is highly conserved in many species, including Drosophila  melanogaster and Caenorhabditis elegans. Recently, the Drosophila ortholog of mammalian PGAM5 (dPGAM5) has been shown to exacerbate mitochondrial degeneration and dopaminergic neuronal cell death in a model of Parkinson’s disease induced by mutation of the Drosophila PINK1 gene [73]. Because PINK1 has been shown to play a critical role in the induction of mitophagy, as mentioned in Section 3, the genetic interaction of PINK1 and PGAM5 suggests that PGAM5 might be involved in mitochondrial quality control.

PGAM5 has several unique and interesting features, as mentioned above. Although its physiological functions have been largely unknown, recent findings have suggested that PGAM5 functions as a regulator of multiple cell death pathways. In the following subsections, we will summarize the recent reports on PGAM5 as a cell death regulator.

5.1. PGAM5 in Necroptosis

Necrosis is one type of cell death that is morphologically distinct from apoptosis [6]. During apoptosis, cells break into small membrane-wrapped vesicles known as apoptotic bodies. In contrast, necrosis is characterized by a discontinuous cytoplasmic membrane and organelle swelling. Until recently, apoptosis was considered to be the sole form of programmed cell death, whereas necrosis was regarded as an unregulated and uncontrollable process. However, the recent identification of components that transduce necrosis-specific signals suggests that necrosis is also a regulated process. Following this finding, necrosis came to be defined as “necroptosis.” Several more additional recent studies have revealed that necroptosis participates or is involved in the pathogenesis of various diseases, including ischaemic injury, neurodegeneration, and viral infection.

Necroptosis is induced by the ligation of death domain-containing receptors, including TNF receptor 1 (TNFR1) and TNFR2, under specific conditions in which caspases are inhibited [6]. The main components of the necroptosis signaling pathway are two Ser/Thr kinases, receptor-interacting protein 1 (RIP1), and RIP3 [7476]. Upon necrosis-inducing stimuli, RIP1 and RIP3 interact with each other to form a complex (Figure 5(a)). Because the kinase activity of RIP1 and RIP3 is essential for the execution of necroptosis, the identification of their substrates has been a major focus of recent research. The pharmacological inhibition of RIP1 abolishes the recruitment of RIP3 and thereby inhibits RIP3 activation, suggesting that RIP1 is upstream of RIP3 [75]. Although the substrates of RIP3 have been remained elusive, recent studies have uncovered some critical factors that act downstream of RIP3 in necroptosis. Interestingly, one of these proteins is PGAM5 [77] (Figure 5(b)). PGAM5 has two splice variants in humans, PGAM5L and PGAM5S. Upon exposure to necroptosis-inducing stimuli, both forms of PGAM5 are phosphorylated by RIP3 [77]. The RIP3-mediated phosphorylation of PGAM5 enhances its protein phosphatase activity. As mentioned in Section 2, mitochondrial fission has been implicated in cell death. Interestingly, PGAM5S appears to activate Drp1, most likely through dephosphorylation of the inhibitory Ser637 site of Drp1 and thereby promotes mitochondrial fission. Although it remains elusive how mitochondrial fission promotes necroptosis, the pronecrotic role of PGAM5 may be exerted in part by the regulation of mitochondrial fission [77].

5.2. PGAM5 in Apoptosis

Some recent reports have also revealed the involvement of PGAM5 in apoptosis. The comprehensive screening of Bcl-xL-binding proteins identified PGAM5 as one Bcl-xL interactor [78]. Recently, it has been reported that PGAM5 bridges Keap1 and Bcl-xL and facilitates the Keap1-E3 ligase complex-mediated degradation of Bcl-xL. Because the Keap1-dependent degradation of antiapoptotic Bcl-xL protein enhances etoposide-induced apoptosis, PGAM5 appears to serve a proapoptotic function [79].

However, our recent analysis of dPGAM5-deficient flies has revealed the antiapoptotic function of PGAM5 [80]. Null mutants of dPGAM5 exhibited increased vulnerability to heat shock stress. Interestingly, dPGAM5 deficiency in the mushroom body, a brain structure that plays a central role in higher brain functions such as olfactory learning and memory, is sufficient for vulnerability to heat shock stress, indicating that dPGAM5 in the mushroom body plays a critical role in whole-body response to heat shock stress. Importantly, phosphatase-inactive dPGAM5 could not rescue this vulnerability, indicating that the role of dPGAM5 in heat shock response is dependent on its phosphatase activity. Moreover, after heat shock treatment, apoptotic cells are detected in the mushroom body of dPGAM5-deficient flies but not in wild-type flies, indicating that dPGAM5 protects against heat shock stress by preventing apoptosis in the mushroom body. Although the detailed molecular mechanisms through which dPGAM5 prevents apoptosis against heat shock stress are not known, we currently consider that dPGAM5 might sense heat shock stress-induced mitochondrial defects, such as the accumulation of heat-damaged proteins within mitochondria, and transduce signals from mitochondria to other cellular compartments [80].

6. Conclusions

Here, we have discussed the phosphorylation-dependent regulation of mitochondrial proteins in the mitochondrial and cellular stress responses. Mitochondrial protein phosphorylation contributes to the regulation of mitochondrial dynamics and mitophagy, which are important to maintain mitochondrial quality and ultimately ensure cellular homeostasis. Furthermore, mitochondrial protein phosphorylation is also involved in cell stress-induced programmed cell death, such as apoptosis and necroptosis. Further studies of mitochondrial protein phosphorylation will lead to a better understanding of the mitochondrial and cellular stress responses and related pathophysiological phenomena.


The authors thank all the members of the Cell Signaling Laboratory for valuable discussions. This work was supported by the Japanese Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology (PRESTO) program, Grants-in-Aid for Scientific Research (KAKENHI) from the Japanese Society for the Promotion of Science (JSPS) and Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT), Global Center of Education and Research for Chemical Biology of the Diseases, the “Understanding of molecular and environmental bases for brain health” conducted under the Strategic Research Program for Brain Sciences by MEXT, the Naito Foundation Natural Science Scholarship, the Cosmetology Research Foundation, and the Tokyo Biochemical Research Foundation.


  1. H. M. McBride, M. Neuspiel, and S. Wasiak, “Mitochondria: more than just a powerhouse,” Current Biology, vol. 16, no. 14, pp. R551–R560, 2006. View at: Publisher Site | Google Scholar
  2. X. Wang, “The expanding role of mitochondria in apoptosis,” Genes and Development, vol. 15, no. 22, pp. 2922–2933, 2001. View at: Google Scholar
  3. A. P. West, G. S. Shadel, and S. Ghosh, “Mitochondria in innate immune responses,” Nature Reviews Immunology, vol. 11, no. 6, pp. 389–402, 2011. View at: Publisher Site | Google Scholar
  4. D. C. Wallace, “A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine,” Annual Review of Genetics, vol. 39, pp. 359–407, 2005. View at: Publisher Site | Google Scholar
  5. S. A. Detmer and D. C. Chan, “Functions and dysfunctions of mitochondrial dynamics,” Nature Reviews Molecular Cell Biology, vol. 8, no. 11, pp. 870–879, 2007. View at: Publisher Site | Google Scholar
  6. P. Vandenabeele, L. Galluzzi, T. Vanden Berghe, and G. Kroemer, “Molecular mechanisms of necroptosis: an ordered cellular explosion,” Nature Reviews Molecular Cell Biology, vol. 11, no. 10, pp. 700–714, 2010. View at: Publisher Site | Google Scholar
  7. D. J. Pagliarini and J. E. Dixon, “Mitochondrial modulation: reversible phosphorylation takes center stage?” Trends in Biochemical Sciences, vol. 31, no. 1, pp. 26–34, 2006. View at: Publisher Site | Google Scholar
  8. H. Chen, A. Chomyn, and D. C. Chan, “Disruption of fusion results in mitochondrial heterogeneity and dysfunction,” The Journal of Biological Chemistry, vol. 280, no. 28, pp. 26185–26192, 2005. View at: Publisher Site | Google Scholar
  9. H. Chen, J. M. McCaffery, and D. C. Chan, “Mitochondrial fusion protects against neurodegeneration in the cerebellum,” Cell, vol. 130, no. 3, pp. 548–562, 2007. View at: Publisher Site | Google Scholar
  10. G. Twig, A. Elorza, A. J. A. Molina et al., “Fission and selective fusion govern mitochondrial segregation and elimination by autophagy,” The EMBO Journal, vol. 27, no. 2, pp. 433–446, 2008. View at: Publisher Site | Google Scholar
  11. H. Chen, S. A. Detmer, A. J. Ewald, E. E. Griffin, S. E. Fraser, and D. C. Chan, “Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development,” Journal of Cell Biology, vol. 160, no. 2, pp. 189–200, 2003. View at: Publisher Site | Google Scholar
  12. N. Ishihara, M. Nomura, A. Jofuku et al., “Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice,” Nature Cell Biology, vol. 11, no. 8, pp. 958–966, 2009. View at: Publisher Site | Google Scholar
  13. M. V. Alavi, S. Bette, S. Schimpf et al., “A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy,” Brain, vol. 130, no. 4, pp. 1029–1042, 2007. View at: Publisher Site | Google Scholar
  14. S. Züchner, I. V. Mersiyanova, M. Muglia et al., “Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A,” Nature Genetics, vol. 36, no. 5, pp. 449–451, 2004. View at: Publisher Site | Google Scholar
  15. C. Alexander, M. Votruba, U. E. A. Pesch et al., “OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28,” Nature Genetics, vol. 26, no. 2, pp. 211–215, 2000. View at: Publisher Site | Google Scholar
  16. C. Delettre, G. Lenaers, J. M. Griffoin et al., “Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy,” Nature Genetics, vol. 26, no. 2, pp. 207–210, 2000. View at: Publisher Site | Google Scholar
  17. C. R. Chang and C. Blackstone, “Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology,” The Journal of Biological Chemistry, vol. 282, no. 30, pp. 21583–21587, 2007. View at: Publisher Site | Google Scholar
  18. G. M. Cereghetti, A. Stangherlin, O. Martins De Brito et al., “Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 41, pp. 15803–15808, 2008. View at: Publisher Site | Google Scholar
  19. L. C. Gomes, G. D. Benedetto, and L. Scorrano, “During autophagy mitochondria elongate, are spared from degradation and sustain cell viability,” Nature Cell Biology, vol. 13, no. 5, pp. 589–598, 2011. View at: Publisher Site | Google Scholar
  20. H. Kim, M. Scimia, D. Wilkinson et al., “Fine-tuning of Drp1/Fis1 availability by AKAP121/Siah2 regulates mitochondrial adaptation to hypoxia,” Molecular Cell, vol. 44, no. 4, pp. 532–544, 2011. View at: Publisher Site | Google Scholar
  21. D. Tondera, S. Grandemange, A. Jourdain et al., “SlP-2 is required for stress-induced mitochondrial hyperfusion,” The EMBO Journal, vol. 28, no. 11, pp. 1589–1600, 2009. View at: Publisher Site | Google Scholar
  22. D. L. Beene and J. D. Scott, “A-kinase anchoring proteins take shape,” Current Opinion in Cell Biology, vol. 19, no. 2, pp. 192–198, 2007. View at: Publisher Site | Google Scholar
  23. K. Nakayama, I. J. Frew, M. Hagensen et al., “Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia,” Cell, vol. 117, no. 7, pp. 941–952, 2004. View at: Publisher Site | Google Scholar
  24. T. Tatsuta and T. Langer, “Quality control of mitochondria: protection against neurodegeneration and ageing,” The EMBO Journal, vol. 27, no. 2, pp. 306–314, 2008. View at: Publisher Site | Google Scholar
  25. N. Mizushima and M. Komatsu, “Autophagy: renovation of cells and tissues,” Cell, vol. 147, no. 4, pp. 728–741, 2011. View at: Publisher Site | Google Scholar
  26. M. Tsukada and Y. Ohsumi, “Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae,” FEBS Letters, vol. 333, no. 1-2, pp. 169–174, 1993. View at: Publisher Site | Google Scholar
  27. D. J. Klionsky, J. M. Cregg, W. A. Dunn et al., “A unified nomenclature for yeast autophagy-related genes,” Developmental Cell, vol. 5, no. 4, pp. 539–545, 2003. View at: Publisher Site | Google Scholar
  28. N. Mizushima, T. Yoshimori, and Y. Ohsumi, “The role of atg proteins in autophagosome formation,” Annual Review of Cell and Developmental Biology, vol. 27, pp. 107–132, 2011. View at: Publisher Site | Google Scholar
  29. H. Nakatogawa, K. Suzuki, Y. Kamada, and Y. Ohsumi, “Dynamics and diversity in autophagy mechanisms: lessons from yeast,” Nature Reviews Molecular Cell Biology, vol. 10, no. 7, pp. 458–467, 2009. View at: Publisher Site | Google Scholar
  30. K. Okamoto, N. Kondo-Okamoto, and Y. Ohsumi, “Mitochondria-anchored receptor Atg32 mediates degradation of mitochondria via selective autophagy,” Developmental Cell, vol. 17, no. 1, pp. 87–97, 2009. View at: Publisher Site | Google Scholar
  31. T. Kanki, K. Wang, Y. Cao, M. Baba, and D. J. Klionsky, “Atg32 is a mitochondrial protein that confers selectivity during mitophagy,” Developmental Cell, vol. 17, no. 1, pp. 98–109, 2009. View at: Publisher Site | Google Scholar
  32. Y. Aoki, T. Kanki, Y. Hirota et al., “Phosphorylation of serine 114 on Atg32 mediates mitophagy,” Molecular Biology of the Cell, vol. 22, no. 17, pp. 3206–3217, 2011. View at: Publisher Site | Google Scholar
  33. H. Saito, “Regulation of cross-talk in yeast MAPK signaling pathways,” Current Opinion in Microbiology, vol. 13, no. 6, pp. 677–683, 2010. View at: Publisher Site | Google Scholar
  34. Y. Kurihara, T. Kanki, Y. Aoki et al., “Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast,” The Journal of Biological Chemistry, vol. 287, no. 5, pp. 3265–3272, 2012. View at: Google Scholar
  35. E. M. Valente, P. M. Abou-Sleiman, V. Caputo et al., “Hereditary early-onset Parkinson's disease caused by mutations in PINK1,” Science, vol. 304, no. 5674, pp. 1158–1160, 2004. View at: Publisher Site | Google Scholar
  36. J. W. Pridgeon, J. A. Olzmann, L. S. Chin, and L. Li, “PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1,” PLoS Biology, vol. 5, no. 7, article e172, 2007. View at: Publisher Site | Google Scholar
  37. H. Plun-Favreau, K. Klupsch, N. Moisoi et al., “The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1,” Nature Cell Biology, vol. 9, no. 11, pp. 1243–1252, 2007. View at: Publisher Site | Google Scholar
  38. J. Park, S. B. Lee, S. Lee et al., “Mitochondrial dysfunction in DrosophilaPINK1 mutants is complemented by parkin,” Nature, vol. 441, no. 7097, pp. 1157–1161, 2006. View at: Publisher Site | Google Scholar
  39. D. Narendra, A. Tanaka, D. F. Suen, and R. J. Youle, “Parkin is recruited selectively to impaired mitochondria and promotes their autophagy,” Journal of Cell Biology, vol. 183, no. 5, pp. 795–803, 2008. View at: Publisher Site | Google Scholar
  40. D. P. Narendra, S. M. Jin, A. Tanaka et al., “PINK1 is selectively stabilized on impaired mitochondria to activate Parkin,” PLoS Biology, vol. 8, no. 1, Article ID e1000298, 2010. View at: Publisher Site | Google Scholar
  41. N. Matsuda, S. Sato, K. Shiba et al., “PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy,” Journal of Cell Biology, vol. 189, no. 2, pp. 211–221, 2010. View at: Publisher Site | Google Scholar
  42. S. M. Jin, M. Lazarou, C. Wang, L. A. Kane, D. P. Narendra, and R. J. Youle, “Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL,” Journal of Cell Biology, vol. 191, no. 5, pp. 933–942, 2010. View at: Publisher Site | Google Scholar
  43. R. J. Youle and D. P. Narendra, “Mechanisms of mitophagy,” Nature Reviews Molecular Cell Biology, vol. 12, no. 1, pp. 9–14, 2011. View at: Publisher Site | Google Scholar
  44. S. R. Yoshii, C. Kishi, N. Ishihara, and N. Mizushima, “Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane,” The Journal of Biological Chemistry, vol. 286, no. 22, pp. 19630–19640, 2011. View at: Publisher Site | Google Scholar
  45. N. C. Chan, A. M. Salazar, A. H. Pham et al., “Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy,” Human Molecular Genetics, vol. 20, no. 9, pp. 1726–1737, 2011. View at: Publisher Site | Google Scholar
  46. X. Wang, D. Winter, G. Ashrafi et al., “PINK1 and Parkin target miro for phosphorylation and degradation to arrest mitochondrial motility,” Cell, vol. 147, no. 4, pp. 893–906, 2011. View at: Publisher Site | Google Scholar
  47. H. Chen and D. C. Chan, “Mitochondrial dynamics—fusion, fission, movement, and mitophagy—in neurodegenerative diseases,” Human Molecular Genetics, vol. 18, no. 2, pp. R169–R176, 2009. View at: Google Scholar
  48. Z.-H. Sheng and Q. Cai, “Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration,” Nature Reviews Neuroscience, vol. 13, no. 2, pp. 77–93, 2012. View at: Google Scholar
  49. S. J. Riedl and Y. Shi, “Molecular mechanisms of caspase regulation during apoptosis,” Nature Reviews Molecular Cell Biology, vol. 5, no. 11, pp. 897–907, 2004. View at: Publisher Site | Google Scholar
  50. R. J. Youle and A. Strasser, “The BCL-2 protein family: opposing activities that mediate cell death,” Nature Reviews Molecular Cell Biology, vol. 9, no. 1, pp. 47–59, 2008. View at: Publisher Site | Google Scholar
  51. E. Yang, J. Zha, J. Jockel, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer, “Bad, a heterodimeric partner for Bcl-x(L), and Bcl-2, displaces Bax and promotes cell death,” Cell, vol. 80, no. 2, pp. 285–291, 1995. View at: Google Scholar
  52. J. Zha, H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer, “Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L),” Cell, vol. 87, no. 4, pp. 619–628, 1996. View at: Publisher Site | Google Scholar
  53. S. R. Datta, A. Katsov, L. Hu et al., “14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation,” Molecular Cell, vol. 6, no. 1, pp. 41–51, 2000. View at: Google Scholar
  54. A. Bonni, A. Brunet, A. E. West, S. R. Datta, M. A. Takasu, and M. E. Greenberg, “Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms,” Science, vol. 286, no. 5443, pp. 1358–1362, 1999. View at: Publisher Site | Google Scholar
  55. H. Harada, B. Becknell, M. Wilm et al., “Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A,” Molecular Cell, vol. 3, no. 4, pp. 413–422, 1999. View at: Publisher Site | Google Scholar
  56. A. Schürmann, A. F. Mooney, L. C. Sanders et al., “p21-Activated kinase 1 phosphorylates the death agonist Bad and protects cells from apoptosis,” Molecular and Cellular Biology, vol. 20, no. 2, pp. 453–461, 2000. View at: Publisher Site | Google Scholar
  57. S. Cotteret, Z. M. Jaffer, A. Beeser, and J. Chernoff, “p21-activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5526–5539, 2003. View at: Publisher Site | Google Scholar
  58. T. L. T. Aho, J. Sandholm, K. J. Peltola, H. P. Mankonen, M. Lilly, and P. J. Koskinen, “Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site,” FEBS Letters, vol. 571, no. 1–3, pp. 43–49, 2004. View at: Publisher Site | Google Scholar
  59. S. R. Datta, H. Dudek, T. Xu et al., “Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery,” Cell, vol. 91, no. 2, pp. 231–241, 1997. View at: Publisher Site | Google Scholar
  60. H. Harada, J. S. Andersen, M. Mann, N. Terada, and S. J. Korsmeyer, “p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 17, pp. 9666–9670, 2001. View at: Publisher Site | Google Scholar
  61. S. R. Datta, A. M. Ranger, M. Z. Lin et al., “Survival factor-mediated BAD phosphorylation raises the mitochondrial threshold for apoptosis,” Developmental Cell, vol. 3, no. 5, pp. 631–643, 2002. View at: Publisher Site | Google Scholar
  62. N. Donovan, E. B. E. Becker, Y. Konishi, and A. Bonni, “JNK phosphorylation and activation of bad couples the stress-activated signaling pathway to the cell death machinery,” The Journal of Biological Chemistry, vol. 277, no. 43, pp. 40944–40949, 2002. View at: Publisher Site | Google Scholar
  63. Y. Konishi, M. Lehtinen, N. Donovan, and A. Bonni, “Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery,” Molecular Cell, vol. 9, no. 5, pp. 1005–1016, 2002. View at: Publisher Site | Google Scholar
  64. J. Sunayama, F. Tsuruta, N. Masuyama, and Y. Gotoh, “JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3,” Journal of Cell Biology, vol. 170, no. 2, pp. 295–304, 2005. View at: Publisher Site | Google Scholar
  65. J. C. Reed, “Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD,” Science, vol. 284, no. 5412, pp. 339–343, 1999. View at: Google Scholar
  66. S. Haldar, N. Jena, and C. M. Croce, “Inactivation of Bcl-2 by phosphorylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 10, pp. 4507–4511, 1995. View at: Google Scholar
  67. K. Yamamoto, H. Ichijo, and S. J. Korsmeyer, “BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M,” Molecular and Cellular Biology, vol. 19, no. 12, pp. 8469–8478, 1999. View at: Google Scholar
  68. T. Ito, X. Deng, B. Carr, and W. S. May, “Bcl-2 phosphorylation required for anti-apoptosis function,” The Journal of Biological Chemistry, vol. 272, no. 18, pp. 11671–11673, 1997. View at: Publisher Site | Google Scholar
  69. K. Takeda, Y. Komuro, T. Hayakawa et al., “Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic activity as a protein serine/threonine phosphatase to activate ASK1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 30, pp. 12301–12305, 2009. View at: Publisher Site | Google Scholar
  70. M. J. Jedrzejas, “Structure, function, and evolution of phosphoglycerate mutases: comparison with fructose-2,6-bisphosphatase, acid phosphatase, and alkaline phosphatase,” Progress in Biophysics and Molecular Biology, vol. 73, no. 2–4, pp. 263–287, 2000. View at: Publisher Site | Google Scholar
  71. S. C. Lo and M. Hannink, “PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria,” Experimental Cell Research, vol. 314, no. 8, pp. 1789–1803, 2008. View at: Publisher Site | Google Scholar
  72. S. C. Lo and M. Hannink, “PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex,” The Journal of Biological Chemistry, vol. 281, no. 49, pp. 37893–37903, 2006. View at: Publisher Site | Google Scholar
  73. Y. Imai, T. Kanao, T. Sawada et al., “The loss of PGAM5 suppresses the mitochondrial degeneration caused by inactivation of PINK1 in Drosophila,” PLoS Genetics, vol. 6, no. 12, Article ID e1001229, 2010. View at: Google Scholar
  74. Y. Cho, S. Challa, D. Moquin et al., “Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation,” Cell, vol. 137, no. 6, pp. 1112–1123, 2009. View at: Publisher Site | Google Scholar
  75. S. He, L. Wang, L. Miao et al., “Receptor interacting protein Kinase-3 determines cellular necrotic response to TNF-α,” Cell, vol. 137, no. 6, pp. 1100–1111, 2009. View at: Publisher Site | Google Scholar
  76. D. W. Zhang, J. Shao, J. Lin et al., “RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis,” Science, vol. 325, no. 5938, pp. 332–336, 2009. View at: Publisher Site | Google Scholar
  77. Z. Wang, H. Jiang, S. Chen, F. Du, and X. Wang, “The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways,” Cell, vol. 148, no. 1-2, pp. 228–243, 2012. View at: Publisher Site | Google Scholar
  78. P. W. Hammond, J. Alpin, C. E. Rise, M. Wright, and B. L. Kreider, “In Vitro selection and characterization of Bcl-XL-binding proteins from a mix of tissue-specific mRNA display libraries,” The Journal of Biological Chemistry, vol. 276, no. 24, pp. 20898–20906, 2001. View at: Publisher Site | Google Scholar
  79. S. K. Niture and A. K. Jaiswal, “Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis,” The Journal of Biological Chemistry, vol. 286, no. 52, pp. 44542–44556, 2011. View at: Publisher Site | Google Scholar
  80. Y. Ishida, Y. Sekine, H. Oguchi et al., “Prevention of apoptosis by mitochondrial phosphatase PGAM5 in the mushroom body is crucial for heat shock resistance in Drosophila melanogaster,” PLoS ONE, vol. 7, no. 2, Article ID e30265, 2012. View at: Publisher Site | Google Scholar

Copyright © 2012 Yusuke Kanamaru et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles